Literature DB >> 15386359

TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.

Hector Ardila-Osorio1, Catherine Pioche-Durieu, Francine Puvion-Dutilleul, Bernard Clausse, Joëlle Wiels, William Miller, Nancy Raab-Traub, Pierre Busson.   

Abstract

The CD40 receptor and the Epstein-Barr virus oncoprotein LMP1 are both members of the TNF-receptor family and share several signaling mediators, including TRAF2 and TRAF3. Depending on the cell lineage and stage of maturation, LMP1 and CD40 can have synergistic, antagonist or unrelated effects. Previous publications have suggested that both TRAF2 and TRAF3 move into lipid rafts upon LMP1 expression or CD40 activation, whereas their proteolysis is only enhanced by CD40. However CD40-induced proteolysis of TRAF2 has only been reported in murine cells, and there are conflicting data regarding translocation of TRAF2 into lipid rafts. We therefore investigated TRAF2 and TRAF3 modifications induced by CD40 and LMP1 signaling in a panel of human cell lines of lymphoid and epithelial origins. Upon CD40 stimulation, a marked redistribution of TRAF2 into the buoyant raft fraction was observed in all cell lines and was often associated with a similar redistribution of TRAF3. In contrast, only TRAF3 was redistributed into the raft fraction upon LMP1 expression. Moreover parallel changes in subcellular distribution of TRAF2 and TRAF3 were recorded by electron microscopy. A significant decrease in TRAF2 and TRAF3 concentrations triggered by CD40 ligation was observed in only 1 cell line and there was no evidence that this decrease was required for the negative feed-back on JNK activation. TRAF2 redistribution into raft-like complexes thus appears as the most significant event distinctive of CD40 and LMP1 signaling. On the other hand, the parallel influence of CD40 and LMP1 on TRAF3 redistribution is consistent with functional similarities between the CD40-TRAF3 and LMP1-TRAF3 axes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15386359     DOI: 10.1002/ijc.20503

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

2.  Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

3.  Human tumor virus utilizes exosomes for intercellular communication.

Authors:  David G Meckes; Kathy H Y Shair; Aron R Marquitz; Che-Pei Kung; Rachel H Edwards; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

4.  The interactome of EBV LMP1 evaluated by proximity-based BioID approach.

Authors:  Mark A Rider; Mujeeb R Cheerathodi; Stephanie N Hurwitz; Dingani Nkosi; Lauren A Howell; Deanna C Tremblay; Xia Liu; Fanxiu Zhu; David G Meckes
Journal:  Virology       Date:  2018-01-09       Impact factor: 3.616

5.  High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association.

Authors:  Christopher M Wrobel; Timothy R Geiger; Rebecca N Nix; Aaron M Robitaille; Sandra Weigand; Alfredo Cervantes; Miguel Gonzalez; Jennifer M Martin
Journal:  Virus Res       Date:  2013-09-25       Impact factor: 3.303

6.  TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.

Authors:  Julia Hauer; Stephanie Püschner; Parameswaran Ramakrishnan; Ute Simon; Martina Bongers; Christine Federle; Hartmut Engelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

7.  In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.

Authors:  Catherine Pioche-Durieu; Cécile Keryer; Sylvie Souquère; Jacques Bosq; Wolfgang Faigle; Damarys Loew; Mitsuomi Hirashima; Nozomu Nishi; Jaap Middeldorp; Pierre Busson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 8.  Viral effects on the content and function of extracellular vesicles.

Authors:  Nancy Raab-Traub; Dirk P Dittmer
Journal:  Nat Rev Microbiol       Date:  2017-06-26       Impact factor: 60.633

9.  Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation.

Authors:  David G Meckes; Nathan F Menaker; Nancy Raab-Traub
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

10.  Modulation of B-cell exosome proteins by gamma herpesvirus infection.

Authors:  David G Meckes; Harsha P Gunawardena; Robert M Dekroon; Phillip R Heaton; Rachel H Edwards; Sezgin Ozgur; Jack D Griffith; Blossom Damania; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.